Bahilid, Rica Joy C.
HRN: 03-89-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2023
CEFUROXIME 1.5GM (VIAL)
04/12/2023
04/19/2023
IV
1.5g
Q8
Acute Pyelonephritis; G1P0
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes